Primary Hepatocytes- An Emerging Tool for Drug Toxicity Studies? Many newly developed medications turn out to be harmful even after being released onto the market due to unanticipated side effects. These adverse medication responses result in major health problems for patients, as well as financial losses for the pharmaceutical industry owing to drug withdrawal from the market once the licence expires.
Adverse drug responses come in a variety of forms, based on the organ system in the body that is impacted. Drug-induced liver toxicity and acute liver failure are the most common grounds for a drug's discontinuation from the market. The liver’s role in drug metabolism When a pharmaceutical product is introduced into the body, it is processed in several locations throughout the body, including the gut wall, lungs, kidneys, and plasma. Nonetheless, since the liver is engaged in metabolising foreign substances, it is a key target for drug toxicity. The way drugs are removed from the body is determined by their metabolism in the liver. Drugs can also operate as a promoter or inhibitors of drug metabolism enzymes in the liver, affecting drug absorption further. As a result, studying drug-liver interactions and their potential hepatotoxicity is crucial for the development of novel drugs or extending the therapeutic value of existing drugs.